Gabapentin Capsule
Product Images NDC 50090-0896

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-0896). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

A mathematical formula to calculate creatinine clearance (CLCr), incorporating variables for age, weight, serum creatinine level, and an adjustment factor for female patients. This is a text panel showing calculation details, not specific to Gabapentin labeling.*

FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

A line graph showing mean pain scores over 8 weeks comparing placebo and Gabapentin at 3600 mg/day. The x-axis represents weeks including a 4-week dose titration period and a 4-week fixed dose period, while the y-axis shows mean pain scores from 0 to 10. Gabapentin treatment results in a decreasing pain score trend compared to placebo.*

FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

Line graph depicting mean pain scores over a 7-week period comparing placebo with gabapentin at 1800 mg/day and 2400 mg/day doses. The x-axis represents weeks from baseline, including a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 10.*

FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) against gabapentin (GBP) at different dosages in two studies. Study 1 shows 12% response for placebo and 29% for gabapentin 3600 mg. Study 2 shows 14% for placebo, 32% for gabapentin 1800 mg, and 34% for gabapentin 2400 mg.*

FDA Label Image

Gabapentin-fig4 (Gabapentin Fig4)

A scatter plot graph showing differences in percentage on the y-axis versus daily dose in mg on the x-axis. Data points are categorized by three studies labeled a, b, and c, with varying percentage differences across doses ranging from approximately 600 mg to 1800 mg.*

FDA Label Image

Label Image (Lbl500900896)

Gabapentin 300 mg capsules label from A-S Medication Solutions, Libertyville, IL. The label states the dosage strength of 300 mg per capsule and the package contains 100 capsules. Storage instructions indicate to store at 68 to 77 degrees Fahrenheit. The label includes a QR code, lot number, and dosage instruction reference.*

FDA Label Image

Label Image (Lbl500902107)

Gabapentin 400 mg capsules label from A-S Medication Solutions. The label indicates each capsule contains 400 mg of Gabapentin USP. Storage instructions are to keep at 68-77 degrees Fahrenheit. The package contains 90 capsules and includes barcodes and the labeler location in Libertyville, IL.*

FDA Label Image

Label Image (Lbl500903200)

Gabapentin 100 mg capsules labeled by A-S Medication Solutions. The label includes dosage form and strength, storage instructions (store at 68 to 77 degrees Fahrenheit), package count of 30 capsules, a QR code, and product identifiers including NDC 50090-3200-0 and Product No. 5734-0. The label indicates the capsules contain gabapentin USP 100 mg each.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.